Cronograma de promoção EyePoint Pharmaceuticals, Inc.
Agenda avançada
Gráfico simples
Sobre a empresa
Фармацевтическая компания EyePoint Pharmaceuticals, Inc. занимается разработкой и коммерциализацией терапевтических средств для улучшения жизни пациентов с серьезными заболеваниями глаз в США, Китае и Великобритании. Его коммерческие продукты включают YUTIQ для лечения хронического неинфекционного увеита, поражающего задний сегмент глаза; и DEXYCU для лечения послеоперационного воспаления.
Mais detalhes| P/S | 7.53 |
|---|---|
| P/BV | 18.41 |
| EV/EBITDA | -4.1 |
| EBITDA | -0.0443 |
| Цена ао | 8.44 |
| Сайт | https://eyepointpharma.com |
| Выручка | 0.0204 |
| ISIN | US30233G2093 |
| Число акций ао | 0.0389 млрд |
| Валюта | usd |
| IPO date | 2005-01-27 |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Валюта отчета | usd |
| Alteração de preço por dia: | 0% (8.83) |
|---|---|
| Alteração de preço por semana: | +1.38% (8.71) |
| Alteração de preço por mês: | -2.97% (9.1) |
| Alteração de preço em 3 meses: | -16.22% (10.54) |
| Mudança de preço em seis meses: | -57.83% (20.94) |
| Mudança de preço por ano: | +9.01% (8.1) |
| Mudança de preço em 3 anos: | -17.4% (10.69) |
| Mudança de preço em 5 anos: | +451.88% (1.6) |
| Mudança de preço desde o início do ano: | +42.88% (6.18) |
|
|
Subestimação
|
Eficiência
|
|||||||||||||||||||||||||||||||||||||
Dividendos
|
Obrigação
|
Impulso de crescimento
|
|||||||||||||||||||||||||||||||||||||
| ETF | Compartilhar, % | Rentabilidade para o ano, % | Dividendos, % |
|---|---|---|---|
| ProShares Ultra Nasdaq Biotechnology | 0.03087 | 51.697637072723 | 0.85651 |
| Fidelity MSCI Health Care Index ETF | 0.00656 | 13.390080209527 | 1.46057 |
| Goldman Sachs ActiveBeta US Small Cap Equity ETF | 0.0189 | 31.359936575053 | 1.41955 |
| ProShares Hedge Replication ETF | 0.00271 | 5.9237999659878 | 1.47892 |
| Humankind US Stock ETF | 0.00348 | 18.809430395549 | 1.99919 |
| Invesco Nasdaq Biotechnology ETF | 0.04684 | 28.578975171685 | 0.8565 |
| iShares Morningstar Small-Cap ETF | 0.00701 | 30.095066471445 | 1.60498 |
| iShares Morningstar Small-Cap Growth ETF | 0.01385 | 33.628071953382 | 0.72598 |
| iShares Micro-Cap ETF | 0.11302 | 36.318555985322 | 1.54048 |
| iShares Russell 2000 Growth ETF | 0.01526 | 38.042556988 | 0.6026 |
| iShares Russell 3000 ETF | 0.00068 | 32.57283798366 | 1.43482 |
| iShares Morningstar Small-Cap ETF | 0.00701 | 391.25300933451 | 1.60498 |
| iShares Morningstar Small-Cap Growth ETF | 0.01385 | 680.05582339508 | 0.72598 |
| Nuveen ESG Small-Cap ETF | 0.04604 | 29.971671388102 | 1.41019 |
| Direxion Daily Pharmaceutical & Medical Bull 3X Shares | 0.59565 | 86.715867158672 | 1.2989 |
| SPDR Portfolio MSCI Global Stock Market ETF | 0.00225 | 23.600605143722 | 2.19607 |
| ProShares UltraPro Russell2000 | 0.00963 | 89.821266282945 | 1.47873 |
| Vanguard U.S. Momentum Factor ETF | 0.11 | 45.845704753962 | 1.05834 |
| Vanguard Russell 3000 ETF | 0 | 31.87314172448 | 1.43817 |
| Vanguard Russell 2000 Growth ETF | 0.02 | 39.350070246167 | 0.60264 |
| Vanguard Russell 2000 ETF | 0.02 | 35.648084105685 | 1.48801 |
| SPDR S&P Pharmaceuticals ETF | 0.7819 | 29.798803697662 | 1.29889 |
| Principal Healthcare Innovators ETF | 0.04656 | 618.4964157054 | 0.8416 |
| Future Tech ETF | 0.04656 | 426.33969118983 | 0.8416 |
| Supervisor | Cargo | Pagamento | Ano de nascimento |
|---|---|---|---|
| Dr. Jay S. Duker M.D. | President, CEO & Director | 848.5k | 1959 (65 anos) |
| Mr. Michael Pine | Chief Business Officer | 764.85k | 1977 (47 anos) |
| Mr. George O. Elston | Executive VP & CFO | 743.86k | 1965 (59 anos) |
| Mr. Ron I. Honig Esq. | Chief Legal Officer & Company Secretary | N/A | |
| Ms. Jennifer Leonard | Chief People Officer & Senior VP of IT | N/A | |
| Ms. Isabelle Lefebvre | Chief Regulatory Officer | N/A | |
| Mr. Michael J. Maciocio | Senior Vice President of Manufacturing & Operations | N/A | |
| Dr. John B. Landis M.S., Ph.D. | Interim Head of R&D and Director | 63.75k | 1953 (71 ano) |
| Mr. David Scott Jones M.A. | Senior VP & Chief Commercial Officer | 1967 (57 anos) | |
| Dr. Marcia Sellos-Moura Ph.D. | Senior VP and Head of Development & Program Management |
Endereço: United States, Watertown. MA, 480 Pleasant Street - abrir no Google Maps, abrir mapas Yandex
Site: https://eyepointpharma.com
Site: https://eyepointpharma.com
